Stay updated on CA-4948 in CNS Lymphoma: Clinical Trial
Sign up to get notified when there's something new on the CA-4948 in CNS Lymphoma: Clinical Trial page.

Latest updates to the CA-4948 in CNS Lymphoma: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to reflect the closure of enrollment for Parts A1 and A2 of the clinical trial evaluating emavusertib, and it now includes detailed descriptions of the trial's structure, including the non-randomized and randomized components of Parts B and C.SummaryDifference31%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 24, 2025.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous update date of January 24, 2025, and version 2.14.2.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to CA-4948 in CNS Lymphoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 in CNS Lymphoma: Clinical Trial page.